Rhodes NJ, et al. - The impact of prolonged infusion piperacillin-tazobactam schemes on clinical endpoints in severely ill patients, was studied via systematic review and meta-analysis. Across diverse cohorts of severely ill patients, receipt of prolonged infusion of piperacillin-tazobactam was found to be associated with reduced mortality and improved clinical cure rates.